Skip to main content

Table 1 The relationship between miR-126-3p expression and clinicopathological characteristics in human HCC patients

From: MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2

Variables

All patients

miR-126-3p expression

Pvalue

 

(n = 70)

Low*

High*

 

Age (years)

    

≤55

24

12

12

1

>55

46

23

23

 

Gender

    

Male

62

31

31

1

Female

8

4

4

 

Size of tumor (cm)

    

≤5

30

12

18

0.147

>5

40

23

17

 

Number of tumor

    

Single

54

25

29

0.255

Multiple

16

10

6

 

Portal vein invasion

    

Negative

46

22

24

0.615

Positive

24

13

11

 

TNM staging

    

I, II

37

15

23

0.094

III

33

20

13

 

Grade

    

Well + Moderate

61

29

32

0.284

Poor

9

6

3

 

AFP (ng/ml)

    

≤400

39

16

23

0.092

>400

31

19

12

 
  1. *The median expression level was used as the cut-off. Low expression of miR-126-3p in 35 patients was classified as values below the 50th percentile. High miR-126-3p expression in 35 patients was classified as values at or above the 50th percentile.
  2. For analysis of correlation between miR-126-3p expressions and clinical features, chi-square tests were used. Results were considered statistically significant at P <0.05.